Details for New Drug Application (NDA): 206222
✉ Email this page to a colleague
The generic ingredient in ESZOPICLONE is eszopiclone. There are twenty drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the eszopiclone profile page.
Summary for 206222
Tradename: | ESZOPICLONE |
Applicant: | Ipca Labs Ltd |
Ingredient: | eszopiclone |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 206222
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 1MG | ||||
Approval Date: | Dec 29, 2023 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
Approval Date: | Dec 29, 2023 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 3MG | ||||
Approval Date: | Dec 29, 2023 | TE: | AB | RLD: | No |
Complete Access Available with Subscription